Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study.

Sci Rep · 2022 · PMC9043502 · PMID 35478198

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Remarkably, this is already evident for COVID-19: highly significant sub-group effects have been seen in trials demonstrating the efficacy of dexamethasone 4 , 5 and tocilizumab 6 , and progress has been made to uncover their underlying biology 7 .

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.